{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:37:48Z","timestamp":1765960668064,"version":"3.48.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.08.080","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:03:32Z","timestamp":1756742612000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study"],"prefix":"10.1016","author":[{"given":"Zaryab","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Malick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle C.","family":"Lauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-1649","authenticated-orcid":false,"given":"Stanislav N.","family":"Tolkachjov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.08.080_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1130625","article-title":"DPP-4 inhibitors for treating T2DM - hype or hope? An analysis based on the current literature","volume":"10","author":"Saini","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.jaad.2025.08.080_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003550","article-title":"Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study","volume":"11","author":"Pradhan","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.jaad.2025.08.080_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/exd.14228","article-title":"The role of dipeptidyl peptidase-4 in cutaneous disease","volume":"30","author":"Patel","year":"2021","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.08.080_bib4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/cancers16051016","article-title":"Risk factors and innovations in risk assessment for melanoma, basal cell carcinoma, and squamous cell carcinoma","volume":"16","author":"Wunderlich","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2025.08.080_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4082\/kjfm.21.0193","article-title":"Pharmacovigilance and its importance for primary health care professionals","volume":"43","author":"Hamid","year":"2022","journal-title":"Korean J Fam Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225027161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225027161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:26:55Z","timestamp":1765960015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225027161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":5,"alternative-id":["S0190962225027161"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.08.080","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.08.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}